Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

被引：0
|
作者：
C. Belliveau
M. Barkati
G. Delouya
D. Taussky
M. C. Beauchemin
C. Lambert
L. Beaulieu
D. Beliveau-Nadeau
B. Nicolas
J. F. Carrier
E. Vigneault
C. Ménard
机构：
[1] CHUM - Centre Hospitalier de l’Université de Montréal,Radiation Oncology
[2] Université Laval,Radiation Oncology, Centre universitaire de Québec
来源：
Radiation Oncology | / 17卷
关键词：
Prostate cancer; Stereotactic radiotherapy; Focal brachytherapy; Quality of life; Magnetic resonance imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer
    Den, Robert B.
    Greenspan, Jacob
    Doyle, Laura A.
    Harrison, Amy S.
    Peng, Cheng
    Williams, Noelle L.
    Lallas, Costas D.
    Trabulsi, Edouard J.
    Gomella, Leonard G.
    Hurwitz, Mark D.
    Leiby, Benjamin
    Dicker, Adam P.
    BRACHYTHERAPY, 2020, 19 (03) : 282 - 289
  • [42] Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial
    See, Andrew W.
    Conway, Paul
    Frydenberg, Mark
    Haxhimolla, Hodo
    Costello, Anthony J.
    Moon, Daniel
    Ruljancich, Paul
    Grummet, Jeremy
    Pranavan, Ganes
    Peters, Justin
    Smyth, Lloyd M. L.
    Gwini, Stella M.
    Mckenzie, Dean P.
    Bowden, Patrick
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (07) : 1248 - 1256
  • [43] Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials
    Kee, Daniel Lam Cham
    Gal, Jocelyn
    Falk, Alexander T.
    Schiappa, Renaud
    Chand, Marie-Eve
    Gautier, Mathieu
    Doyen, Jerome
    Hannoun-Levi, Jean -Michel
    CANCER TREATMENT REVIEWS, 2018, 70 : 265 - 271
  • [44] Risk factors for urethral stricture following external beam radiotherapy and HDR brachytherapy for prostate cancer
    Groom, Nicki
    Tsang, Yatman
    Lowe, Gerry
    Hoskin, Peter
    BRACHYTHERAPY, 2021, 20 (02) : 302 - 306
  • [45] F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer
    Solanki, Abhishek A.
    Yoo, Ryan K.
    Adams, William
    Davicioni, Elai
    Mysz, Michael L.
    Shea, Steven
    Gupta, Gopal N.
    Showalter, Timothy
    Garant, Aurelie
    Hentz, Courtney
    Farooq, Ahmer
    Baldea, Kristin
    Small, William
    Harkenrider, Matthew M.
    BJU INTERNATIONAL, 2024, 133 (02) : 188 - 196
  • [46] Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)
    Peyraga, G.
    Lizee, T.
    Khalifa, J.
    Blais, E.
    Mauriange-Turpin, G.
    Supiot, S.
    Krhili, S.
    Tremolieres, P.
    Graff-Cailleaud, P.
    CANCER RADIOTHERAPIE, 2021, 25 (04): : 400 - 409
  • [47] A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
    Slevin, Finbar
    Zattoni, Fabio
    Checcucci, Enrico
    Cumberbatch, Marcus G. K.
    Nacchia, Antonio
    Cornford, Philip
    Briers, Erik
    De Meerleer, Gert
    De Santis, Maria
    Eberli, Daniel
    Gandaglia, Giorgio
    Gillessen, Silke
    Grivas, Nikolaos
    Liew, Matthew
    Espinos, Estefania E. Linares
    Oldenburg, Jan
    Oprea-Lager, Daniela E.
    Ploussard, Guillaume
    Rouviere, Olivier
    Schoots, Ivo G.
    Smith, Emma Jane
    Stranne, Johan
    Tilki, Derya
    Smith, Catrin Tudur
    Van Den Bergh, Roderick C. N.
    Van Oort, Inge M.
    Wiegel, Thomas
    Yuan, Cathy Y.
    Van den Broeck, Thomas
    Henry, Ann M.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 677 - 696
  • [48] Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost
    Ben Aicha, Ibtihel
    Hathout, Lara
    Carignan, Damien
    Despres, Philippe
    Lavallee, Marie-Claude
    Aubin, Sylviane
    Beaulieu, Luc
    Lacroix, Frederic
    Foster, William
    Martin, Andre-Guy
    Vigneault, Eric
    BRACHYTHERAPY, 2020, 19 (05) : 584 - 588
  • [49] Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial
    Zapatero, Almudena
    Castro, Pablo
    Roch, Maria
    Carnero, Pablo Rodriguez
    Carroceda, Sara
    Rosciupchin, Alexandra Elena Stoica
    Hernandez, Sergio Honorato
    Cogorno, Leopoldo
    Iturriaga, Alfonso Gomez
    Garcia, David Buchser
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [50] Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
    Siva, Shankar
    Bressel, Mathias
    Murphy, Declan G.
    Shaw, Mark
    Chander, Sarat
    Violet, John
    Tai, Keen Hun
    Udovicich, Cristian
    Lim, Andrew
    Selbie, Lisa
    Hofman, Michael S.
    Kron, Tomas
    Moon, Daniel
    Goad, Jeremy
    Lawrentschuk, Nathan
    Foroudi, Farshad
    EUROPEAN UROLOGY, 2018, 74 (04) : 455 - 462
12345